Search research articles
Contact Us
Filters
Showing results (451-460 of 568) with videos related to
Page
of 57
Sort By:
Cancers
|
February 11, 2023
Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry Study
Ivan Guerra, Luis Bujanda, Miriam Mañosa, et al.
European Journal of Clinical Investigation
|
July 9, 2024
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study
Ferdinando D'Amico, Luca Massimino, Giulia Palmieri, et al.
Alimentary Pharmacology & Therapeutics
|
March 6, 2024
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
María José García, Sabino Riestra, Aurelien Amiot, et al.
Inflammatory Bowel Diseases
|
February 2, 2012
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response
Lior Katz, Javier P Gisbert, Beth Manoogian, et al.
Lancet (London, England)
|
October 16, 2012
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
David Laharie, Arnaud Bourreille, Julien Branche, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 29, 2026
Th1/Th17 cytokine signatures correlate with Crohn's disease activity in a 54‑week cohort of patients treated with adalimumab
Patricia de Castro-Martínez, Luis G Guijarro, Jorge Monserrat, et al.
Gastroenterology
|
January 6, 2015
Identification of risk loci for Crohn's disease phenotypes using a genome-wide association study
Arnald Alonso, Eugeni Domènech, Antonio Julià, et al.
Journal of Crohn'S & Colitis
|
July 28, 2018
Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease
Carlos Taxonera, Ángel Ponferrada, Sabino Riestra, et al.
Cancers
|
July 2, 2021
Follow-Up Study Confirms the Presence of Gastric Cancer DNA Methylation Hallmarks in High-Risk Precursor Lesions
Antonio Gómez, Miguel L Pato, Luis Bujanda, et al.
Biomedicines
|
March 25, 2022
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease Severity
Luis G Guijarro, David Cano-Martínez, M Val Toledo-Lobo, et al.
Page
of 57
Search research articles
Search
Showing results (451-460 of 568) with videos related to
Sort By:
Page
of 57
Cancers
|
February 11, 2023
Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry Study
Ivan Guerra, Luis Bujanda, Miriam Mañosa, et al.
European Journal of Clinical Investigation
|
July 9, 2024
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study
Ferdinando D'Amico, Luca Massimino, Giulia Palmieri, et al.
Alimentary Pharmacology & Therapeutics
|
March 6, 2024
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
María José García, Sabino Riestra, Aurelien Amiot, et al.
Inflammatory Bowel Diseases
|
February 2, 2012
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response
Lior Katz, Javier P Gisbert, Beth Manoogian, et al.
Lancet (London, England)
|
October 16, 2012
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
David Laharie, Arnaud Bourreille, Julien Branche, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 29, 2026
Th1/Th17 cytokine signatures correlate with Crohn's disease activity in a 54‑week cohort of patients treated with adalimumab
Patricia de Castro-Martínez, Luis G Guijarro, Jorge Monserrat, et al.
Gastroenterology
|
January 6, 2015
Identification of risk loci for Crohn's disease phenotypes using a genome-wide association study
Arnald Alonso, Eugeni Domènech, Antonio Julià, et al.
Journal of Crohn'S & Colitis
|
July 28, 2018
Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease
Carlos Taxonera, Ángel Ponferrada, Sabino Riestra, et al.
Cancers
|
July 2, 2021
Follow-Up Study Confirms the Presence of Gastric Cancer DNA Methylation Hallmarks in High-Risk Precursor Lesions
Antonio Gómez, Miguel L Pato, Luis Bujanda, et al.
Biomedicines
|
March 25, 2022
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease Severity
Luis G Guijarro, David Cano-Martínez, M Val Toledo-Lobo, et al.
Page
of 57